MOD-9012

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameMOD-9012
Drug Alias NameIFN-beta-CTPIFN-beta-1a-CTPLong-Acting IFN-Beta (PROLOR)Interferon-Beta (Modigene)MOD-9013 +[8] 
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionInterferon alpha/beta receptor agonistsImmunomodulators
TargetsInterferon alpha/beta receptor
Therapy Area/IndicationsMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesProlor Biotech
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesProlor Biotech
Active IndicationsN/A
Inactive IndicationsMultiple Sclerosis

Other Information

ATC CodeN/A
Related LinksN/A